Global Biopharmaceutical CMO Market Report 2024

Biopharmaceutical CMO Global Market Report 2024 – By Product (Biologics, Biosimilars), By Source (Mammalian, Non-Mammalian), By Service (Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Biopharmaceutical CMO Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Biopharmaceutical CMO Market Definition And Segments

Biopharmaceutical CMO is a business that provides manufacturing services, with the capacity to produce small quantities for preclinical research and development and more significant numbers needed for clinical trials and commercialization. The biopharmaceutical CMO assists in lowering overall operational risk and time to market.

The main types of biopharmaceuticals CMO products includes biologics and biosimilars. The biologics are used to produce a wide range of products derived from human, animal, or microbial sources as biologic medications. Biologics are substances made from living things or contain some components of them. Vaccines, blood, blood components, cells, allergies, genes, tissues, and recombinant proteins are some of the biologic medications. The biopharmaceutical CMO products come from various sources including mammalian and non-mammalian. The biopharmaceutical CMO services includes manufacturing, fill and finish operations, analytical and qc studies, and packaging.

The biopharmaceutical CMO market covered in this report is segmented –

1) By Product: Biologics, Biosimilars

2) By Source: Mammalian, Non-Mammalian

3) By Service: Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging

The biopharmaceutical CMO market size has grown rapidly in recent years. It will grow from $21.72 billion in 2023 to $24.68 billion in 2024 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to increasing demand for biopharmaceuticals, globalization, rise in healthcare expenditure, regulatory support, increased research funding.

The biopharmaceutical CMO market size is expected to see rapid growth in the next few years. It will grow to $41.87 billion in 2028 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to rise in telehealth and remote trials, global health initiatives, rise in disposable income, global health initiatives. Major trends in the forecast period include advanced therapies dominance, digitalization and industry 4.0, continuous manufacturing, sustainability and green practices.

Robust Venture Capital Investments Fuel Biopharmaceutical CMO Market Growth

An increase in the robustness of venture capital investments for the life science sector is expected to propel the growth of the biopharmaceutical CMO market. The life sciences sector refers to the businesses and organizations that conduct research and development on living beings. The robustness of venture capital investments is a feature describing the capacity of a model, test, or system to function correctly when its parameters or presumptions are changed. As the investment in the life science sector increases, there will be an increase in the manufacturing of biopharmaceuticals. For instance, in September 2021, according to JLL, a US-based company specializing in investment consultancy, the record amount of venture capital was raised in the UK over the last three months, with £1.9 billion raised between 1 June and 26 August 2021. This incredible investment brings the UK total for 2021 to £4.25 billion ($5.787 billion) YTD, up from £2.8 billion in 2020. Therefore, an increase in the robustness of venture capital investments for the life science sector is driving the biopharmaceutical CMO market growth.

Biopharmaceutical CMO Market And Chronic Disease Burden

The increasing burden of chronic diseases is expected to propel the growth of the biopharmaceutical CMO market going forward. Chronic diseases are long-term health conditions that persist over a person's lifetime, often progressing slowly and requiring ongoing medical management. Biopharmaceutical CMOs can enhance the fight against chronic diseases by expediting drug development, ensuring cost-effective production, and maintaining high-quality standards, thereby increasing accessibility and affordability of life-saving medications. For instance, in 2022, according to National Library of Medicine, US Government journal on chronic diseases, the number of people in the United States aged 50 years and older will increase by 61.11% from 137.25 million in 2020 to 221.13 million in 2050. Of the population 50 years and older, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Therefore, increasing burden of chronic diseases drives the biopharmaceutical CMOs market .

Major companies operating in the biopharmaceutical CMO market include Lonza Group AG, Fujifilm Diosynth Biotechnologies USA Inc., Thermo Fisher Scientific Inc., Samsung BioLogics Co. Ltd., WuXi Biologics Co. Ltd., Lonza Ltd., JRS Pharma Group, CMC Biologics AS, Catalent Inc., Boehringer Ingelheim GmbH, Rentschler Biopharma SE, AGC Biologics Inc., Abzena Ltd., AbbVie Inc., AstraZeneca PLC, Bayer AG, Biogen Inc., Bristol-Myers Squibb Co., Eli Lilly and Company, Gilead Sciences Inc., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Roche Holding Ag, Sanofi SA, Takeda Pharmaceuticals Co., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Company, Moderna BioTechnology Company

Biopharmaceutical CMO Market Embraces IoT Technology Advancements

Technological advancement is a key trend gaining popularity in the biopharmaceutical CMO market. Major companies in the biopharmaceutical CMO market are advancing in their new technologies and research and development using Iot. The Internet of Things (IoT) refers to the application of networked sensors and actuators to regulate and observe the environment, the objects that move within it, and the people who act within it. A vast amount of data can be produced by sensors, actuators, and other components integrated into manufacturing machinery and networked computer systems. The data can be analyzed for insights and opportunities to increase production efficiency, automate monitoring and controlling tasks, and enable adaptable manufacturing systems. For instance, in February 2022, M2Cloud, a Korea-based bio-cold chain technology company, along with Thales, a France-based company specializing in IoT communication modules, developed an IoT-based LTE monitoring system for biopharmaceutical monitoring. It is helpful in the real-time monitoring of freezers, refrigerated warehouses, etc., along with tracking the delivery boxes being delivered in real-time. It can remotely verify temperature and position information in real time by just turning on the power. With technologies designed for biopharmaceutical management, it increases the safety of pharmaceutical products.

Biopharmaceutical CMO Market Consolidation Trends

Major companies operating in biopharmaceutical CMO market are actively engaging in mergers and acquisitions to streamline their operations and gain a competitive edge to drive the revenues in the market larger pharmaceutical companies are increasingly opting to outsource manufacturing to specialized CMOs, leading to a competitive landscape defined by major players absorbing smaller firms to enhance their capabilities and global reach. This trend is driven by the need for efficiency, cost-effectiveness, and access to advanced technologies. For instance, in December 2021, Thermo Fisher Scientific acquired PPD, a leading global contract research organization, for $17.4 billion, showcasing the industry's move toward consolidation.

AstraZeneca’s Acquisition Of Alexion Pharmaceuticals

In July 2021, AstraZeneca, a UK-based biopharmaceutical business that develops innovative medicines, acquired Alexion Pharmaceuticals, Inc for an undisclosed amount. Through this acquisition, AstraZeneca will manufacture medicines for rare diseases. AstraZeneca now has a more robust scientific presence in immunology because of Alexion's complement-biology platform and substantial pipeline. Alexion Pharmaceuticals, Inc is a USA-based biopharmaceutical company focused on developing drugs and therapies for people living with rare disorders.

North America was the largest region in the biopharmaceutical CMO market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical CMO market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biopharmaceutical CMO market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The biopharmaceutical CMO market includes revenues earned by entities by process development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The biopharmaceutical CMO market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical CMO market statistics, including biopharmaceutical CMO industry global market size, regional shares, competitors with a biopharmaceutical CMO market share, detailed biopharmaceutical CMO market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical CMO industry. This biopharmaceutical CMO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Biopharmaceutical CMO Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $24.68 billion
Revenue Forecast In 2033 $41.87 billion
Growth Rate CAGR of 14.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product: Biologics, Biosimilars
2) By Source: Mammalian, Non-Mammalian
3) By Service: Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Lonza Group AG; Fujifilm Diosynth Biotechnologies USA Inc.; Thermo Fisher Scientific Inc.; Samsung BioLogics Co. Ltd.; WuXi Biologics Co. Ltd.; Lonza Ltd.; JRS Pharma Group; CMC Biologics AS; Catalent Inc.; Boehringer Ingelheim GmbH; Rentschler Biopharma SE; AGC Biologics Inc.; Abzena Ltd.; AbbVie Inc.; AstraZeneca plc; Bayer AG; Biogen Inc.; Bristol-Myers Squibb Co.; Eli Lilly and Company; Gilead Sciences Inc.; GlaxoSmithKline plc; Johnson & Johnson; Merck & Co.; Novartis AG; Pfizer Inc.; Roche Holding Ag; Sanofi SA; Takeda Pharmaceuticals Co.; Teva Pharmaceutical Industries Ltd.; Vertex Pharmaceuticals Company; Moderna BioTechnology Company
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Biopharmaceutical CMO Market Characteristics

    3. Biopharmaceutical CMO Market Trends And Strategies

    4. Biopharmaceutical CMO Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Biopharmaceutical CMO Market Size and Growth

    5.1. Global Biopharmaceutical CMO Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Biopharmaceutical CMO Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Biopharmaceutical CMO Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Biopharmaceutical CMO Market Segmentation

    6.1. Global Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Biologics

    Biosimilars

    6.2. Global Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Mammalian

    Non-Mammalian

    6.3. Global Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Manufacturing

    Fill And Finish Operations

    Analytical And QC Studies

    Packaging

    7. Biopharmaceutical CMO Market Regional And Country Analysis

    7.1. Global Biopharmaceutical CMO Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Biopharmaceutical CMO Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Biopharmaceutical CMO Market  

    8.1. Asia-Pacific Biopharmaceutical CMO Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Biopharmaceutical CMO Market  

    9.1. China Biopharmaceutical CMO Market Overview  

    9.2. China Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Biopharmaceutical CMO Market  

    10.1. India Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Biopharmaceutical CMO Market  

    11.1. Japan Biopharmaceutical CMO Market Overview  

    11.2. Japan Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Biopharmaceutical CMO Market  

    12.1. Australia Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Biopharmaceutical CMO Market  

    13.1. Indonesia Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Biopharmaceutical CMO Market  

    14.1. South Korea Biopharmaceutical CMO Market Overview  

    14.2. South Korea Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Biopharmaceutical CMO Market  

    15.1. Western Europe Biopharmaceutical CMO Market Overview

    15.2. Western Europe Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Biopharmaceutical CMO Market  

    16.1. UK Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Biopharmaceutical CMO Market  

    17.1. Germany Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Biopharmaceutical CMO Market  

    18.5. France Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Biopharmaceutical CMO Market  

    19.9. Italy Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Biopharmaceutical CMO Market  

    20.13. Spain Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Biopharmaceutical CMO Market  

    21.1. Eastern Europe Biopharmaceutical CMO Market Overview

    21.2. Eastern Europe Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Biopharmaceutical CMO Market  

    22.1. Russia Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Biopharmaceutical CMO Market  

    23.1. North America Biopharmaceutical CMO Market Overview

    23.2. North America Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Biopharmaceutical CMO Market  

    24.1. USA Biopharmaceutical CMO Market Overview

    24.2. USA Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Biopharmaceutical CMO Market  

    25.1. Canada Biopharmaceutical CMO Market Overview

    25.2. Canada Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Biopharmaceutical CMO Market  

    26.1. South America Biopharmaceutical CMO Market Overview

    26.2. South America Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Biopharmaceutical CMO Market  

    27.1. Brazil Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Biopharmaceutical CMO Market  

    28.1. Middle East Biopharmaceutical CMO Market Overview

    28.2. Middle East Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Biopharmaceutical CMO Market  

    29.1. Africa Biopharmaceutical CMO Market Overview

    29.2. Africa Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Biopharmaceutical CMO Market Competitive Landscape And Company Profiles

    30.1. Biopharmaceutical CMO Market Competitive Landscape

    30.2. Biopharmaceutical CMO Market Company Profiles

    30.2.1. Lonza Group AG

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Fujifilm Diosynth Biotechnologies USA Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Thermo Fisher Scientific Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Samsung BioLogics Co. Ltd.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. WuXi Biologics Co. Ltd.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Biopharmaceutical CMO Market Competitive Benchmarking

    32. Global Biopharmaceutical CMO Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Biopharmaceutical CMO Market

    34. Biopharmaceutical CMO Market Future Outlook and Potential Analysis

    34.1 Biopharmaceutical CMO Market In 2028 - Countries Offering Most New Opportunities

    34.2 Biopharmaceutical CMO Market In 2028 - Segments Offering Most New Opportunities

    34.3 Biopharmaceutical CMO Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Biopharmaceutical CMO Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Biopharmaceutical CMO Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Lonza Group AG Financial Performance
  • Table 75: Fujifilm Diosynth Biotechnologies USA Inc. Financial Performance
  • Table 76: Thermo Fisher Scientific Inc. Financial Performance
  • Table 77: Samsung BioLogics Co. Ltd. Financial Performance
  • Table 78: WuXi Biologics Co. Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Biopharmaceutical CMO Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Biopharmaceutical CMO Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Lonza Group AG Financial Performance
  • Figure 75: Fujifilm Diosynth Biotechnologies USA Inc. Financial Performance
  • Figure 76: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 77: Samsung BioLogics Co. Ltd. Financial Performance
  • Figure 78: WuXi Biologics Co. Ltd. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the biopesticidesmarket?

The biopesticides include certain types of pesticides derived from natural materials such as animals, plants, bacteria, and certain minerals. Biopesticides are biological, natural substances that manage a wide range of agricultural pests found in forests, gardens, and farmlands. This includes plant-incorporated protectants, biochemical pesticides, and microbial pesticides. For further insights on the biopesticides market, request a sample here

How will the biopesticides market drivers and restraints affect the biopesticides market dynamics? What forces will shape the biopesticides industry going forward?

The biopesticides market major growth driver - growing organic food demand boosts biopesticides market growth. For further insights on the biopesticides market, request a sample here

What is the forecast market size or the forecast market value of the biopesticides market ?

The biopesticides market size has grown rapidly in recent years. It will grow from $6.2 billion in 2023 to $7.4 billion in 2024 at a compound annual growth rate (CAGR) of 19.3%. The growth in the historic period can be attributed to growth in awareness about the environmental and health impacts, increase in government regulations, expansion of organic farming, investments in research and development, rise in disposable income. The biopesticides market size is expected to see rapid growth in the next few years. It will grow to $14.46 billion in 2028 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to rise in agriculture sector, growing global population, rising demand for hygiene and quality food, economic growth. Major trends in the forecast period include precision agriculture integration, digital technologies, market consolidation and partnerships. For further insights on the biopesticides market, request a sample here

How is the biopesticides market segmented?

The biopesticides market is segmented
1) By Type: Bioinsecticides, Biofungicides, Bionematicides, Bioherbicides, Other Types
2) By Source: Microbials, Biochemicals, Beneficial insects
3) By Formulation: Liquid Formulation, Dry Formulation
4) By Mode Of Application: Seed Treatment, Soil Treatment, Foliar Spray, Other Mode Of ApplicationsFor further insights on the biopesticides market,
request a sample here

Which region has the largest share of the biopesticides market? What are the other regions covered in the report?

North America was the largest region in the biopesticides market in 2023. Asia-Pacific is expected to be the fastest-growing region in the market share. The regions covered in the biopesticides market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the biopesticides market, request a sample here.

Who are the major players in the biopesticides market?

Major companies operating in the biopesticides market include BASF SE, Syngenta AG, Bayer AG, Marrone Bio Innovations Inc., Novozymes A/S, Koppert B.V., FMC Corporation, International Panaacea Limited, Som Phytopharma India Limited, BioWorks Inc., Valent Biosciences LLC, Andermatt Biocontrol AG, Isagro S.p.A., Certis USA LLC, DowDuPont Inc., The Stockton Group Ltd., InVivo Group, Vegalab S.A., Biobest Group NV, STK Bio-ag technologies Ltd., Bionema Limited, Corteva Inc., Sumitomo Chemical Co. Ltd., Omnia Holdings Limited, Amit Biotech Private Limited, Agbiochem Inc., AgBiTech Pty Ltd., Arbico Organics, Arysta LifeScience Limited, Stoller Enterprises Inc., Terramera PlantHealth, Aphea.Bio NV, Pluton Biosciences Inc., Phoreus Biotech Inc., Provivi Inc., Vestaron Corporation, Agragene Inc., Phytelligence Inc., Symbiota Inc. For further insights on the biopesticides market, request a sample here.

What are the key trends in the biopesticides market?

Major trend in the biopesticides market - biopesticides market: advancements in bacterial strain technology. For further insights on the biopesticides market, request a sample here.

What are the major opportunities in the biopesticides market? What are the strategies for the biopesticides market?

For detailed insights on the major opportunities and strategies in the biopesticides market, request a sample here.

How does the biopesticides market relate to the overall economy and other similar markets?

For detailed insights on biopesticides market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the biopesticides industry?

For detailed insights on the mergers and acquisitions in the biopesticides industry, request a sample here.

What are the key dynamics influencing the biopesticides market growth? SWOT analysis of the biopesticides market.

For detailed insights on the key dynamics influencing the biopesticides market growth and SWOT analysis of the biopesticides industry, request a sample here.